Volume 2, Issue 1 (February 2017)                   JNFS 2017, 2(1): 97-104 | Back to browse issues page

XML Print

Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (3046 Views)

Background: Previous researches reported inconclusive findings on the interaction of Helicobacter pylori (H.pylori) infection with body indices, although, most of these studies used body mass index (BMI) to assess such an association. The aim of this study was to investigate the association of H.pylori seropositivity with anthropometric indices as well as blood pressure (BP) among a group of young population in Zahedan, a city in south-east of Iran. Methods: A total of 363 undergraduate students participated in this cross-sectional study, in 2014. Serum IgG antibodies against H.pylori were measured and the cut-off level of antibody titers more than or equal to 20 was considered as H.pylori positive. Anthropometric indices and BP were measured using standard protocols. Results: Data analysis indicated that H.pylori seropositivity was equal to 45.7% . H.pylori positive participants had significantly lower mean values of BMI (P = 0.01), waist circumference (WC), and waist to height ratio (WHtR) which was marginally significant (P = 0.05) compared to H.pylori negative participants. No significant differences were found in waist to hip ratio (WHpR), as well as systolic blood pressure (SBP) and diastolic blood pressure (DBP) between the two groups. Although, after adjustment for confounding factors, higher values
of BMI (OR = 1.12, 95% CI = 1.003-3.2) and WHtR (OR = 1.04, 95%
CI = 1.001-2.71) were positively correlated with higher odds of H.pylori positivity. Conclusions: H.pylori positivity was correlated with higher BMI and WHtR after adjusting for other variables, but no correlation was observed for WC, WHpR, or BP among a group of young undergraduate students in south-east of Iran.

Full-Text [PDF 440 kb]   (1045 Downloads) |   |   Full-Text (HTML)  (533 Views)  
Type of article: orginal article | Subject: public specific
Received: 2016/12/4 | Published: 2017/02/1 | ePublished: 2017/02/1

1. Arslan E, Atilgan H & Yavasoglu I 2009. The prevalence of Helicobacter pylori in obese subjects. European journal of internal medicine. 20 (7): 695-697.
2. Ashwell M, Gunn P & Gibson S 2012. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity. 13 (3): 275-286.
3. Boylan MR, Khalili H, Huang ES & Chan AT 2014. Measures of adiposity are associated with increased risk of peptic ulcer. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 12 (10): 1688-1694.
4. Browning LM, Hsieh SD & Ashwell M 2010. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutrition research reviews. 23 (2): 247-269.
5. Chen LW, et al. 2015a. Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study. PloS one. 10 (5): e0128671.
6. Chen TP, et al. 2015b. Helicobacter Pylori Infection is Positively Associated with Metabolic Syndrome in Taiwanese Adults: a Cross-Sectional Study. Helicobacter. 20 (3): 184-191.
7. Eusebi LH, Zagari RM & Bazzoli F 2014. Epidemiology of Helicobacter pylori infection. Helicobacter. 19 Suppl 1: 1-5.
8. Felley C, et al. 2012. Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia. World journal of gastroenterology. 18 (17): 2076-2083.
9. Hussain SA & Hamid S 2014. Helicobacter pylori in humans: Where are we now? Advanced biomedical research. 3: 63.
10. Lender N, et al. 2014. Review article: Associations between Helicobacter pylori and obesity--an ecological study. Alimentary pharmacology & therapeutics. 40 (1): 24-31.
11. Mancia G, et al. 2013. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of hypertension. 31 (7): 1281-1357.
12. Naja F, et al. 2012. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter. 17 (6): 444-451.
13. Rahmani A, et al. 2015. Investigation of the Prevalence of Obesity in Iran: a Systematic Review and Meta-Analysis Study. Acta medica Iranica. 53 (10): 596-607.
14. Sayehmiri F, et al. 2014. A Systematic Review and Meta-Analysis Study to Investigate the Prevalence of Helicobacter pylori and the Sensitivity of its Diagnostic Methods in Iran. Iranian Red Crescent medical journal. 16 (6): e12581.
15. Sepanlou SG, et al. 2015. Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran. Archives of Iranian medicine. 18 (3): 144-152.
16. Shrivastava SR, Shrivastava PS & Ramasamy J 2014. The determinants and scope of public health interventions to tackle the global problem of hypertension. International journal of preventive medicine. 5 (7): 807-812.
17. Sotuneh N, Hosseini SR, Shokri-Shirvani J, Bijani A & Ghadimi R 2014. Helicobacter pylori infection and metabolic parameters: is there an association in elderly population? International journal of preventive medicine. 5 (12): 1537-1542.
18. Tan HJ & Goh KL 2012. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. Journal of digestive diseases. 13 (7): 342-349.
19. Vahdat K, et al. 2013. Association of pathogen burden and hypertension: the Persian Gulf Healthy Heart Study. American journal of hypertension. 26 (9): 1140-1147.
20. Vijayvergiya R & Vadivelu R 2015. Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World journal of cardiology. 7 (3): 134-143.
21. Vo HD, et al. 2015. Inverse correlation between Helicobacter pylori colonization and obesity in a cohort of inner city children. Helicobacter. 20 (1): 64-68.
22. Wang Y, et al. 2014. Homocysteine as a risk factor for hypertension: a 2-year follow-up study. PloS one. 9 (10): e108223.
23. Whalen MB & Massidda O 2015. Helicobacter pylori: enemy, commensal or, sometimes, friend? Journal of infection in developing countries. 9 (6): 674-678.
24. WHO 2011. World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. .
25. Wong F, Rayner-Hartley E & Byrne MF 2014. Extraintestinal manifestations of Helicobacter pylori: a concise review. World journal of gastroenterology. 20 (34): 11950-11961.
26. Xu C, et al. 2014. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter. 19 (6): 437-442.
27. Zhang Y, et al. 2015. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. Journal of infection in developing countries. 9 (9): 945-953.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.